G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-thio-p-Nitrophenyl |
|
[beta]-1-thio-p-Nitrophenyl | |
| B4GALT3 | UDP-Gal |
|
4-Me-lumbelyl-[beta] |
|
4-Me-lumbelyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl | |
| B4GALT1 | UDP-Gal |
|
|
| Pathway Name | Organism |
|---|---|
| E.coli O1A | Escherichia coli |
| E.coli O1A1 | Escherichia coli |
| E.coli O1B | Escherichia coli |
| E.coli O1C | Escherichia coli |
| E.coli O2 | Escherichia coli |
| E.coli O21 | Escherichia coli |
| E.coli O23A | Escherichia coli |
| E.coli O25 | Escherichia coli |
| E.coli O26 | Escherichia coli |
| E.coli O27 | Escherichia coli |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 35737812 | Pathogen-sugar interactions revealed by universal saturation transfer analysis | Buchanan CJ | 2022 Jul 22 |
|
| 35863378 | Organizing structural principles of the IL-17 ligand–receptor axis | Wilson SC | 2022 Jul 21 |
|
| 35889515 | Structural Insights into the Role of β3 nAChR Subunit in the Activation of Nicotinic Receptors | Giastas P | 2022 Jul 20 |
|
| 35858452 | Structural basis for high-voltage activation and subtype-specific inhibition of human Nav1.8 | Huang X | 2022 Jul 19 |
|
| 35849637 | In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding | Bate N | 2022 Jul 18 |
|
| 35858383 | Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes | Mikolajek H | 2022 Jul 15 |
|
| 35887161 | Disruption of O-GlcNAcylation Homeostasis Induced Ovarian Granulosa Cell Injury in Bovine | Wang TF | 2022 Jul 15 |
|
| 35835865 | Architecture of the human erythrocyte ankyrin-1 complex | Vallese F | 2022 Jul 14 |
|
| 35833347 | Discovery of Selective Nanomolar Inhibitors for Insulin-Regulated Aminopeptidase Based on α-Hydroxy-β-amino Acid Derivatives of Bestatin | Vourloumis D | 2022 Jul 14 |
|
| 35748909 | Synthesis of cyclic α-1,4-oligo-N-acetylglucosamine ‘cyclokasaodorin’ via a one-pot electrochemical polyglycosylation–isomerization–cyclization process | Endo H | 2022 Jul 14 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025